Nuvectis Pharma, Inc. (NVCT) Insider Trading -- Recent Executive & Director Transactions

9 insiders reported 39 Form 4 transactions for Nuvectis Pharma, Inc. (NVCT) over the past 18 months (most recent 2026-07-01). Recent activity: BENTSUR RON (Chairman & CEO) Buy 12,500 shares, Mosseri Marlio Charles (Insider) Buy 50,000 shares, Oliviero James F III (Director) Buy 35,000 shares, Hoberman Kenneth (Director) Buy 35,000 shares, Kaplan Matthew L. (Director) Buy 35,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-01BENTSUR RONChairman & CEOBuy12,500$250,000
2026-07-01Mosseri Marlio CharlesInsiderBuy50,000$916,000
2026-06-12Oliviero James F IIIDirectorBuy35,000$0
2026-06-12Hoberman KennethDirectorBuy35,000$0
2026-06-12Kaplan Matthew L.DirectorBuy35,000$0
2026-06-12Sanchez JuanDirectorBuy35,000$0
2026-01-09Poradosu EnriqueChief Science & Business OffBuy150,000$0
2026-01-09Carson Michael J.Vice President, FinanceBuy61,200$0
2026-01-09BENTSUR RONChairman & CEOBuy150,000$0
2026-01-09Shemesh ShayChief Dev. & Ops. OfficerBuy150,000$0
2025-11-06Kaplan Matthew L.DirectorBuy11,000$64,240
2025-11-06Sanchez JuanDirectorBuy13,000$75,270
2025-11-06BENTSUR RONChairman & CEOBuy5,000$28,600
2025-10-31Sanchez JuanDirectorBuy30,000$0
2025-10-29Mosseri Marlio CharlesInsiderBuy46,900$284,214
2025-10-29Mosseri Marlio CharlesInsiderBuy35,034$215,459
2025-10-29Mosseri Marlio CharlesInsiderBuy72,836$457,410
2025-06-24Mosseri Marlio CharlesInsiderBuy5,603$44,768
2025-06-20Mosseri Marlio CharlesInsiderBuy5,399$43,786
2025-06-20Mosseri Marlio CharlesInsiderBuy28,043$225,746
2025-06-12Hoberman KennethDirectorBuy30,000$0
2025-06-12Kaplan Matthew L.DirectorBuy30,000$0
2025-06-12Oliviero James F IIIDirectorBuy30,000$0
2025-05-13Mosseri Marlio CharlesInsiderBuy21,167$171,664
2025-05-12Mosseri Marlio CharlesInsiderBuy100$899

Source: SEC Form 4 filings · as of 2026-07-01